Corvus Pharmaceuticals, Inc. (CRVS)
Total Valuation
CRVS has a market cap or net worth of $40.50 million. The enterprise value is -$19.05 million.
Market Cap | 40.50M |
Enterprise Value | -19.05M |
Important Dates
The next earnings date is Monday, August 1, 2022, before market open.
Estimated Earnings Date | Aug 1, 2022 |
Ex-Dividend Date | n/a |
Share Statistics
CRVS has 46.55 million shares outstanding. The number of shares has increased by 34.88% in one year.
Shares Outstanding | 46.55M |
Shares Change (YoY) | +34.88% |
Shares Change (QoQ) | -0.11% |
Owned by Insiders (%) | 3.72% |
Owned by Institutions (%) | 59.29% |
Float | 28.77M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 0.45 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.95, with a Debt / Equity ratio of 0.04.
Current Ratio | 6.95 |
Quick Ratio | 6.83 |
Debt / Equity | 0.04 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Financial Efficiency
Return on equity (ROE) is -41.10%, which is considered low. The company has a ROIC of -87.10%.
Return on Equity (ROE) | -41.10% |
Return on Assets (ROA) | -36.40% |
Return on Capital (ROIC) | -87.10% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.43M |
Employee Count | 28 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.96% in the last 52 weeks. The beta is 1.07, so CRVS's price volatility has been similar to the market average.
Beta (1Y) | 1.07 |
52-Week Price Change | -63.96% |
50-Day Moving Average | 1.04 |
200-Day Moving Average | 1.69 |
Average Volume (30 Days) | 268,482 |
Short Selling Information
The latest short interest is 191,612, so 0.41% of the outstanding shares have been sold short.
Short Interest | 191,612 |
Short % of Shares Out | 0.41% |
Short % of Float | 0.67% |
Short Ratio (days to cover) | 0.91 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -34.56M |
Net Income | -39.96M |
EBITDA | -39.55M |
EBIT | -39.96M |
Earnings Per Share (EPS) | -$0.89 |
Balance Sheet
The company has $62.94 million in cash and $3.39 million in debt, giving a net cash position of $59.55 million or $1.28 per share.
Cash & Cash Equivalents | 62.94M |
Total Debt | 3.39M |
Net Cash | 59.55M |
Net Cash Per Share | $1.28 |
Book Value | 89.72M |
Book Value Per Share | 1.93 |
Working Capital | 55.10M |
Cash Flow
In the last 12 months, operating cash flow was -$34.35 million and capital expenditures -$5,000, giving a free cash flow of -$34.36 million.
Operating Cash Flow | -34.35M |
Capital Expenditures | -5,000 |
Free Cash Flow | -34.36M |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CRVS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Earnings Yield | -98.66% |
FCF Yield | -84.83% |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Buyback Yield | -34.88% |
Shareholder Yield | -34.88% |
Analyst Forecast
The average price target for CRVS is $6.50, which is 647.13% higher than the current price. The consensus rating is "Buy".
Price Target | $6.50 |
Price Target Difference | 647.13% |
Analyst Consensus | Buy |
Analyst Count | 10 |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |